Abstract
A conference presentation and paper resulting from a summer researching in the Haematology/Oncology Department of Wake Medical Center, NC. This project analyzed the ability of a cancer-eradicating drug, bis chloroethyl nitrosourea, to successfully cross the blood-brain barrier to reach the target glioblastoma (brain cancer) cells, measuring the amount of drug that was delivered across the semi-permeable, sheath membrane.
| Original language | English |
|---|---|
| Title of host publication | CERTL (Center of Excellence in Reading, Teaching, Learning) |
| Publication status | Published - 2007 |
Keywords
- glioblastoma
- cancer
- ONCOLOGY DRUG DEVELOPMENT
- PROTEIN ADSORPTION
